- Tonix Pharmaceuticals Holding Corp to Host KOL Webinar TranscriptJan 31, 2024
- Tonix Pharmaceuticals Holding Corp at ThinkEquity Conference TranscriptOct 19, 2023
- Tonix Pharmaceuticals Holding Corp At The June 1st Virtual Investor Summit TranscriptJun 01, 2023
- Tonix Pharmaceuticals Holding Corp At Investor Summit (Virtual) TranscriptMar 29, 2023
- Tonix Pharmaceuticals announces acquisition of Healion Bio antiviral portfolio TranscriptFeb 23, 2023
- Tonix Pharmaceuticals Holding Corpinterview with Dr. Seth Lederman, MD, and CEO TranscriptFeb 13, 2023
- Tonix Pharmaceuticals discusses exclusive license of potential monoclonal antibodies TranscriptFeb 01, 2023
- Tonix Pharmaceuticals Holding Corp at EBD Group Biotech Showcase TranscriptJan 10, 2023
- Tonix Pharmaceuticals Holding Corp at ThinkEquity Conference TranscriptOct 26, 2022
- Tonix Pharmaceuticals Holding Corp at Q2 Investor Summit TranscriptMay 04, 2022
- Tonix Pharmaceuticals Holding Corp at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 27, 2022
- Tonix Pharmaceuticals Holding Corp at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 21, 2022
- Tonix Pharmaceuticals Holding Corp at Biotechnology Industry Organization (BIO) CEO & Investor Conference (Virtual) - Virtual Presentation TranscriptFeb 14, 2022
- Tonix Pharmaceuticals Holding Corp at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 23, 2021
- Tonix Pharmaceuticals Holding Corp at ICR Virtual Conference TranscriptJan 14, 2021
- Tonix Pharmaceuticals Holding Corp Business Update TranscriptDec 07, 2020
- Tonix Pharmaceuticals Holding Corp at SNN Network Virtual Conference TranscriptAug 06, 2020
- Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase TranscriptApr 29, 2020
- Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase TranscriptApr 22, 2020
- Tonix Pharmaceuticals Holding Corp at Tarsier Capital Management Spring Summit TranscriptMar 25, 2020
- Tonix Pharmaceuticals Holding Corp at Noble Financial Emerging Growth Investor Conference TranscriptFeb 18, 2020
Tonix Pharmaceuticals Holding Corp at ThinkEquity Conference Transcript
My name is Nick Christian. I'm with ThinkEquity. Our next presenting company is Tonix Pharmaceuticals, so I'll turn it over to them.
Hi. Thank you very much. Thank you to ThinkEquity for having Tonix at this conference, and welcome to everyone in person and also attending via webcast. I am Jessica Morris, the Chief Operating Officer with Tonix Pharmaceuticals.
Tonix is a publicly traded company. We're traded on NASDAQ under the ticker TNXP. So here is our standard Safe Harbor statement. I will be making forward-looking statements, and I refer you to our SEC filings for complete information.
So Tonix is a clinical-stage biopharmaceutical company. And ultimately our mission, our vision is to invent and develop new innovative therapies as well as new vaccines for people in need around the world. And how do we propose to do that? This is covered in our investment highlights. So I'll start at the top.
We have a diverse and robust pipeline
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)